Poliovirus 2C region functions during encapsidation of viral RNA

Journal of Virology

Volumn 71, Issue 11, 1997, Pages 8759-8765

  Vance, Lori M ^a   Moscufo, Nicola ^b,d   Chow, Marie ^b,c   Heinz, Beverly A ^a  

^a ELI LILLY AND COMPANY   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

^c UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

5 (3,4 DICHLOROPHENYL)METHYLHYDANTOIN; ANTIVIRUS AGENT; GUANIDINE; HYDANTOIN DERIVATIVE; UNCLASSIFIED DRUG; VIRUS RNA;

AMINO ACID SUBSTITUTION; ARTICLE; CONTROLLED STUDY; HELA CELL; HUMAN; HUMAN CELL; NONHUMAN; POLIOMYELITIS VIRUS; PRIORITY JOURNAL; SITE DIRECTED MUTAGENESIS; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS CULTURE; VIRUS GENOME; VIRUS INHIBITION; VIRUS MUTANT; VIRUS REPLICATION; VIRUS RESISTANCE;

EID: 0030765991     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.71.11.8759-8765.1997     Document Type: Article

References (40)

1. Ansardi, D., and C. Morrow. 1995. Amino acid substitutions in the poliovirus maturation cleavage site affect assembly and result in accumulation of provirions. J. Virol. 69:1540-1547.
2. Baltera, R., and D. Tershak. 1989. Guanidine-resistant mutants of poliovirus have distinct mutations in peptide 2C. J. Virol. 63:4441-4444.
3. Basavappa, R., R. Syed, O. Flore, J. P. Icenogle, D. J. Filman, and J. M. Hogle. 1994. Role and mechanism of the maturation cleavage of VP0 in poliovirus assembly: structure of the empty capsid assembly intermediate at 2.9Å resolution. Protein Sci. 3:1651-1669.
4. Bienz, K., D. Egger, T. Pfister, and M. Troxler. 1992. Structural and functional characterization of the poliovirus replication complex. J. Virol. 66: 2740-2747.
5. Bienz, K., D. Egger, M. Troxler, and L. Pasamontes. 1990. Structural organization of poliovirus RNA replication is mediated by viral proteins of the P2 genomic region. J. Virol. 64:1156-1163.
6. Caliguiri, L., and I. Tamm. 1968. Action of guanidine on the replication of poliovirus RNA. Virology 35:408-417.
7. Caliguiri, L. A., J. J. McSharry, and G. W. Lawrence. 1980. Effect of arildone on modification of poliovirus in vitro. Virology 105:86-93.
8. Crowther, D., and J. Melnick. 1961. Studies of the inhibitory action of guanidine on poliovirus multiplication in cell cultures. Virology 15:65-74.
9. Dever, T., M. Glynias, and W. Merrick. 1987. GTP-binding domain: three consensus sequence elements with distinct spacing. Proc. Natl. Acad. Sci. USA 84:1814-1818.
10. Dove, A. W., and V. R. Racaniello. 1997. Cold-adapted poliovirus mutants bypass a postentry replication block. J. Virol. 71:4728-4735.
11. Fernandez-Tomas, C. B., and D. Baltimore. 1973. Morphogenesis of poliovirus. H. Demonstration of a new intermediate, the provirion. J. Virol. 12:1122-1130.
12. Fernandez-Tomas, C. B., N. Guttman, and D. Baltimore. 1973. Morphogenesis of poliovirus. III. Formation of provirion in cell-free extracts. J. Virol. 12:1181-1183.
13. Gerzon, K., C. Ryan, and D. De Long. 1974. Method of virus suppression by hydantoins. US patent 3,790,6733.
14. Gorbalenya, A., V. Blinov, A. Donchenko, and E. Koonin. 1989. An NTP-binding motif is the most conserved sequence in a highly diverged monophyletic group of proteins involved in positive strand RNA viral replication. J. Mol. Evol. 28:256-268.
15. Guttman, N., and D. Baltimore. 1977. Morphogenesis of poliovirus. IV. Existence of particles sedimenting at 150S and having the properties of provirion. J. Virol. 23:363-367.
16. Heinz, B., R. Rueckert, D. Shepard, F. Dutko, M. McKinlay, M. Fancher, M. Rossmann, J. Badger, and T. Smith. 1989. Genetic and molecular analyses of spontaneous mutants of human rhinovirus 14 that are resistant to an antiviral compound. J. Virol. 63:2476-2485.
17. Heinz, B., and L. Vance. 1995. The antiviral compound enviroxime targets the 3A coding region of rhinovirus and poliovirus. J. Virol. 69:4189-4197.
18. Heinz, B., and L. Vance. 1996. Sequence determinants of 3A-mediated resistance to enviroxime in rhinoviruses and enteroviruses. J. Virol. 70:4854-4857.
19. Holland, J., K. Spindler, E. Horodyski, E. Grabau, S. Nichol, and S. Vande-Pol. 1982. Rapid evolution of RNA genomes. Science 245:1577-1585.
20. Jacobson, M., and D. Baltimore. 1968. Morphogenesis of poliovirus. J. Mol. Biol. 33:369-378.
21. Kirkegaard, K., and D. Baltimore. 1986. The mechanism of RNA recombination in poliovirus. Cell 47:433-443.
22. Li, J.-P., and D. Baltimore. 1988. Isolation of poliovirus 2C mutants defective in viral RNA synthesis. J. Virol. 62:4016-4024.
23. Li, J.-P., and D. Baltimore. 1990. An intragenic revertant of a poliovirus 2C mutant has an uncoating defect. J. Virol. 64:1102-1107.
24. Mirzayan, C., and E. Wimmer. 1992. Genetic analysis of an NTP-binding motif in poliovirus polypeptide 2C. Virology 189:547-555.
25. Mirzayan, C., and E. Wimmer. 1994. Biochemical studies on poliovirus polypeptide 2C: evidence for ATPase activity. Virology 199:176-187.
26. Moscufo, N., and M. Chow. 1992. Myristate-protein interactions in poliovirus: interactions of VP4 threonine-28 contribute to the structural conformation of assembly intermediates and the stability of assembled virions. J. Virol. 66:6849-6857.
27. Moscufo, N., J. Simons, and M. Chow. 1991. Myristoylation is important at multiple stages in poliovirus assembly. J. Virol. 65:2372-2380.
28. Pfister, T., L. Pasamontes, M. Troxler, D. Egger, and K. Bienz. 1992. Immunocytochemical localization of capsid-related particles in subcellular fractions of poliovirus-infected cells. Virology 188:676-684.
29. Pincus, S., D. Diamond, E. Emini, and E. Wimmer. 1986. Guanidine-selected mutants of poliovirus: mapping of point mutations to polypeptide 2C. J. Virol. 57:638-646.
30. Pincus, S., and E. Wimmer. 1986. Production of guanidine-resistant and -dependent poliovirus mutants from cloned cDNA: mutations in polypeptide 2C are directly responsible for altered guanidine sensitivity. J. Virol. 60:793-796.
31. Rodriguez, P., and L. Carrasco. 1993. Poliovirus protein 2C has ATPase and GTPase activities. J. Biol. Chem. 268:8105-8110.
32. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
33. Selden, R. 1989. Analysis of RNA by Northern hybridization, p. 158-159. In F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, K. Strahl, P. Wang-Iverson, and S. Bonitz (ed.), Short protocols in molecular biology. Greene Publishing Associates and Wiley-Interscience, New York, N.Y.
34. Shepard, D., B. Heinz, and R. Rueckert. 1993. WIN 52035-2 inhibits both attachment and eclipse of human rhinovirus 14. J. Virol. 67:2245-2254.
35. Smith, T., M. Kremer, M. Luo, G. Vriend, E. Arnold, G. Kamer, M. Rossman, M. McKinlay, G. Diana, and M. Otto. 1989. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science 233:1286-1293.
36. Takeda, J., R. Kuhn, C.-F. Yang, T. Takegami, and E. Wimmer. 1986. Initiation of poliovirus plus-strand RNA synthesis in a membrane complex of infected HeLa cells. J. Virol. 60:43-53.
37. Tershak, D. 1984. Association of poliovirus proteins with the endoplasmic reticulum. J. Virol. 52:777-783.
38. Teterina, N., K. Kean, A. Gorbalenya, V. Agol, and M. Girard. 1992. Analyses of the functional significance of amino acid residues in the putative NTP-binding pattern of the poliovirus 2C protein. J. Gen. Virol. 73:1977-1986.
39. Tolskaya, E., L. Romanova, M. Kolesnikova, A. Gmyl, A. Gorbalenya, and V. Agol. 1994. Genetic studies on the poliovirus 2C protein, and NTPase. A plausible mechanism of guanidine effect on the 2C function and evidence for the importance of 2C oligomerization. J. Mol. Biol. 236:1310-1323.
40. Underwood, G., C. Wisner, S. Weed, and J. Gray. 1962. Coe virus: growth characteristics in HeLa cells and in mice. Am. J. Hyg. 76:124-136.